Transfidelity for protein stability in Alzheimer's disease
Authorizes CerebrumDAO to co-invest ($50,000) alongside VitaDAO (which separately committed its own $50,000) in Project Transfidelity, on the Molecule Catalyst platform, improving protein-synthesis accuracy to reduce misfolding in neurodegenerative disease. Three senior reviewer assessments cited solid science but immature chemistry.
Vote result
| Choice | Votes (NEURON) | Share |
|---|---|---|
| For | 11,357,745,144.11 | 100.0% |
| Against | 0 | 0.0% |
| Abstain | 0 | 0.0% |
Quorum: 3,870,000,000 NEURON